HEADER STRUCTURAL PROTEIN 25-FEB-09 3GEF TITLE CRYSTAL STRUCTURE OF THE R482W MUTANT OF LAMIN A/C COMPND MOL_ID: 1; COMPND 2 MOLECULE: LAMIN-A/C; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: LAMIN A/C GLOBULAR DOMAIN; COMPND 5 SYNONYM: 70 KDA LAMIN, RENAL CARCINOMA ANTIGEN NY-REN-32; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: LAMIN A/C 435-552, LMN1, LMNA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET41A KEYWDS IMMUNOGLOBULIN FOLD, LAMIN, CARDIOMYOPATHY, CHARCOT-MARIE-TOOTH KEYWDS 2 DISEASE, DISEASE MUTATION, INTERMEDIATE FILAMENT, LIMB-GIRDLE KEYWDS 3 MUSCULAR DYSTROPHY, LIPOPROTEIN, NUCLEUS, PHOSPHOPROTEIN, KEYWDS 4 PRENYLATION, STRUCTURAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR E.MAGRACHEVA,S.KOZLOV,C.STUART,A.WLODAWER,A.ZDANOV REVDAT 4 06-SEP-23 3GEF 1 REMARK REVDAT 3 20-OCT-21 3GEF 1 SEQADV LINK REVDAT 2 19-NOV-14 3GEF 1 HETATM HETNAM VERSN REVDAT 1 04-AUG-09 3GEF 0 JRNL AUTH E.MAGRACHEVA,S.KOZLOV,C.L.STEWART,A.WLODAWER,A.ZDANOV JRNL TITL STRUCTURE OF THE LAMIN A/C R482W MUTANT RESPONSIBLE FOR JRNL TITL 2 DOMINANT FAMILIAL PARTIAL LIPODYSTROPHY (FPLD). JRNL REF ACTA CRYSTALLOGR.,SECT.F V. 65 665 2009 JRNL REFN ESSN 1744-3091 JRNL PMID 19574635 JRNL DOI 10.1107/S1744309109020302 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 82.2 REMARK 3 NUMBER OF REFLECTIONS : 68652 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 6970 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3672 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 320 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.89100 REMARK 3 B22 (A**2) : -11.43400 REMARK 3 B33 (A**2) : 7.54300 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.018 REMARK 3 BOND ANGLES (DEGREES) : 2.000 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3GEF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-FEB-09. REMARK 100 THE DEPOSITION ID IS D_1000051757. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-JUN-07 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.09 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 68652 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 45.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 82.2 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.06200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 31.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1IFR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.9M SODIUM CITRATE, 20MM DTT, 0.1M REMARK 280 SODIUM CACODYLATE, PH 6.3, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.09750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 49.37500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.01750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 49.37500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.09750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.01750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG C 545 CG CD NE CZ NH1 NH2 REMARK 470 ARG D 545 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP D 552 O HOH D 708 1.96 REMARK 500 OG1 THR D 436 O HOH D 563 2.00 REMARK 500 O HOH B 583 O HOH B 706 2.00 REMARK 500 O ASN C 473 O HOH C 646 2.05 REMARK 500 O HOH A 406 O HOH A 560 2.06 REMARK 500 O HOH A 406 O HOH A 665 2.13 REMARK 500 OD1 ASN D 466 O HOH D 570 2.13 REMARK 500 OD1 ASN B 473 O HOH B 591 2.15 REMARK 500 O HOH A 588 O HOH C 571 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 541 NE - CZ - NH1 ANGL. DEV. = 3.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 507 97.54 -163.29 REMARK 500 SER B 507 79.95 -152.24 REMARK 500 GLU C 448 4.67 -69.20 REMARK 500 SER C 507 77.55 -176.46 REMARK 500 SER D 507 81.57 -154.35 REMARK 500 LYS D 515 -87.17 -39.36 REMARK 500 REMARK 500 REMARK: NULL DBREF 3GEF A 436 552 UNP P02545 LMNA_HUMAN 436 552 DBREF 3GEF B 436 552 UNP P02545 LMNA_HUMAN 436 552 DBREF 3GEF C 436 552 UNP P02545 LMNA_HUMAN 436 552 DBREF 3GEF D 436 552 UNP P02545 LMNA_HUMAN 436 552 SEQADV 3GEF SER A 435 UNP P02545 EXPRESSION TAG SEQADV 3GEF TRP A 482 UNP P02545 ARG 482 ENGINEERED MUTATION SEQADV 3GEF SER B 435 UNP P02545 EXPRESSION TAG SEQADV 3GEF TRP B 482 UNP P02545 ARG 482 ENGINEERED MUTATION SEQADV 3GEF SER C 435 UNP P02545 EXPRESSION TAG SEQADV 3GEF TRP C 482 UNP P02545 ARG 482 ENGINEERED MUTATION SEQADV 3GEF SER D 435 UNP P02545 EXPRESSION TAG SEQADV 3GEF TRP D 482 UNP P02545 ARG 482 ENGINEERED MUTATION SEQRES 1 A 118 SER THR SER GLY ARG VAL ALA VAL GLU GLU VAL ASP GLU SEQRES 2 A 118 GLU GLY LYS PHE VAL ARG LEU ARG ASN LYS SER ASN GLU SEQRES 3 A 118 ASP GLN SER MET GLY ASN TRP GLN ILE LYS ARG GLN ASN SEQRES 4 A 118 GLY ASP ASP PRO LEU LEU THR TYR TRP PHE PRO PRO LYS SEQRES 5 A 118 PHE THR LEU LYS ALA GLY GLN VAL VAL THR ILE TRP ALA SEQRES 6 A 118 ALA GLY ALA GLY ALA THR HIS SER PRO PRO THR ASP LEU SEQRES 7 A 118 VAL TRP LYS ALA GLN ASN THR TRP GLY CSD GLY ASN SER SEQRES 8 A 118 LEU ARG THR ALA LEU ILE ASN SER THR GLY GLU GLU VAL SEQRES 9 A 118 ALA MET ARG LYS LEU VAL ARG SER VAL THR VAL VAL GLU SEQRES 10 A 118 ASP SEQRES 1 B 118 SER THR SER GLY ARG VAL ALA VAL GLU GLU VAL ASP GLU SEQRES 2 B 118 GLU GLY LYS PHE VAL ARG LEU ARG ASN LYS SER ASN GLU SEQRES 3 B 118 ASP GLN SER MET GLY ASN TRP GLN ILE LYS ARG GLN ASN SEQRES 4 B 118 GLY ASP ASP PRO LEU LEU THR TYR TRP PHE PRO PRO LYS SEQRES 5 B 118 PHE THR LEU LYS ALA GLY GLN VAL VAL THR ILE TRP ALA SEQRES 6 B 118 ALA GLY ALA GLY ALA THR HIS SER PRO PRO THR ASP LEU SEQRES 7 B 118 VAL TRP LYS ALA GLN ASN THR TRP GLY CSD GLY ASN SER SEQRES 8 B 118 LEU ARG THR ALA LEU ILE ASN SER THR GLY GLU GLU VAL SEQRES 9 B 118 ALA MET ARG LYS LEU VAL ARG SER VAL THR VAL VAL GLU SEQRES 10 B 118 ASP SEQRES 1 C 118 SER THR SER GLY ARG VAL ALA VAL GLU GLU VAL ASP GLU SEQRES 2 C 118 GLU GLY LYS PHE VAL ARG LEU ARG ASN LYS SER ASN GLU SEQRES 3 C 118 ASP GLN SER MET GLY ASN TRP GLN ILE LYS ARG GLN ASN SEQRES 4 C 118 GLY ASP ASP PRO LEU LEU THR TYR TRP PHE PRO PRO LYS SEQRES 5 C 118 PHE THR LEU LYS ALA GLY GLN VAL VAL THR ILE TRP ALA SEQRES 6 C 118 ALA GLY ALA GLY ALA THR HIS SER PRO PRO THR ASP LEU SEQRES 7 C 118 VAL TRP LYS ALA GLN ASN THR TRP GLY CSD GLY ASN SER SEQRES 8 C 118 LEU ARG THR ALA LEU ILE ASN SER THR GLY GLU GLU VAL SEQRES 9 C 118 ALA MET ARG LYS LEU VAL ARG SER VAL THR VAL VAL GLU SEQRES 10 C 118 ASP SEQRES 1 D 118 SER THR SER GLY ARG VAL ALA VAL GLU GLU VAL ASP GLU SEQRES 2 D 118 GLU GLY LYS PHE VAL ARG LEU ARG ASN LYS SER ASN GLU SEQRES 3 D 118 ASP GLN SER MET GLY ASN TRP GLN ILE LYS ARG GLN ASN SEQRES 4 D 118 GLY ASP ASP PRO LEU LEU THR TYR TRP PHE PRO PRO LYS SEQRES 5 D 118 PHE THR LEU LYS ALA GLY GLN VAL VAL THR ILE TRP ALA SEQRES 6 D 118 ALA GLY ALA GLY ALA THR HIS SER PRO PRO THR ASP LEU SEQRES 7 D 118 VAL TRP LYS ALA GLN ASN THR TRP GLY CSD GLY ASN SER SEQRES 8 D 118 LEU ARG THR ALA LEU ILE ASN SER THR GLY GLU GLU VAL SEQRES 9 D 118 ALA MET ARG LYS LEU VAL ARG SER VAL THR VAL VAL GLU SEQRES 10 D 118 ASP MODRES 3GEF CSD A 522 CYS 3-SULFINOALANINE MODRES 3GEF CSD B 522 CYS 3-SULFINOALANINE MODRES 3GEF CSD C 522 CYS 3-SULFINOALANINE MODRES 3GEF CSD D 522 CYS 3-SULFINOALANINE HET CSD A 522 8 HET CSD B 522 8 HET CSD C 522 8 HET CSD D 522 8 HETNAM CSD 3-SULFINOALANINE HETSYN CSD S-CYSTEINESULFINIC ACID; S-SULFINOCYSTEINE FORMUL 1 CSD 4(C3 H7 N O4 S) FORMUL 5 HOH *320(H2 O) HELIX 1 1 GLY A 501 GLY A 503 5 3 HELIX 2 2 GLY B 501 GLY B 503 5 3 HELIX 3 3 GLY C 501 GLY C 503 5 3 SHEET 1 A 4 VAL A 440 VAL A 445 0 SHEET 2 A 4 PHE A 451 ASN A 456 -1 O ARG A 453 N GLU A 444 SHEET 3 A 4 VAL A 494 ALA A 499 -1 O ILE A 497 N VAL A 452 SHEET 4 A 4 ASP A 511 TRP A 514 1 O LEU A 512 N TRP A 498 SHEET 1 B 2 GLN A 462 SER A 463 0 SHEET 2 B 2 THR A 488 LEU A 489 -1 O LEU A 489 N GLN A 462 SHEET 1 C 8 LEU B 479 TRP B 482 0 SHEET 2 C 8 GLN B 468 ASN B 473 -1 N ARG B 471 O LEU B 479 SHEET 3 C 8 LEU B 526 ILE B 531 -1 O ILE B 531 N GLN B 468 SHEET 4 C 8 GLU B 537 GLU B 551 -1 O ALA B 539 N LEU B 530 SHEET 5 C 8 GLU D 537 GLU D 551 -1 O THR D 548 N VAL B 550 SHEET 6 C 8 SER D 525 ILE D 531 -1 N LEU D 530 O ALA D 539 SHEET 7 C 8 GLN D 468 ASN D 473 -1 N GLN D 468 O ILE D 531 SHEET 8 C 8 LEU D 479 TRP D 482 -1 O LEU D 479 N ARG D 471 SHEET 1 D10 LEU A 479 TRP A 482 0 SHEET 2 D10 GLN A 468 ASN A 473 -1 N ILE A 469 O TYR A 481 SHEET 3 D10 SER A 525 ILE A 531 -1 O ILE A 531 N GLN A 468 SHEET 4 D10 GLU A 537 GLU A 551 -1 O ALA A 539 N LEU A 530 SHEET 5 D10 GLU B 537 GLU B 551 -1 O LYS B 542 N VAL A 549 SHEET 6 D10 GLU D 537 GLU D 551 -1 O THR D 548 N VAL B 550 SHEET 7 D10 GLU C 537 GLU C 551 -1 N LYS C 542 O VAL D 549 SHEET 8 D10 LEU C 526 ILE C 531 -1 N LEU C 526 O LEU C 543 SHEET 9 D10 GLN C 468 ASN C 473 -1 N LYS C 470 O ALA C 529 SHEET 10 D10 LEU C 479 TRP C 482 -1 O LEU C 479 N ARG C 471 SHEET 1 E 4 VAL B 440 VAL B 445 0 SHEET 2 E 4 PHE B 451 ASN B 456 -1 O ARG B 453 N GLU B 444 SHEET 3 E 4 VAL B 494 ALA B 499 -1 O ILE B 497 N VAL B 452 SHEET 4 E 4 ASP B 511 TRP B 514 1 O TRP B 514 N TRP B 498 SHEET 1 F 2 GLN B 462 SER B 463 0 SHEET 2 F 2 THR B 488 LEU B 489 -1 O LEU B 489 N GLN B 462 SHEET 1 G 4 VAL C 440 VAL C 445 0 SHEET 2 G 4 PHE C 451 ASN C 456 -1 O ARG C 453 N GLU C 444 SHEET 3 G 4 VAL C 494 ALA C 499 -1 O ILE C 497 N VAL C 452 SHEET 4 G 4 ASP C 511 TRP C 514 1 O LEU C 512 N TRP C 498 SHEET 1 H 2 GLN C 462 SER C 463 0 SHEET 2 H 2 THR C 488 LEU C 489 -1 O LEU C 489 N GLN C 462 SHEET 1 I 4 VAL D 440 VAL D 445 0 SHEET 2 I 4 PHE D 451 ASN D 456 -1 O ARG D 453 N GLU D 444 SHEET 3 I 4 VAL D 494 ALA D 499 -1 O ILE D 497 N VAL D 452 SHEET 4 I 4 ASP D 511 TRP D 514 1 O TRP D 514 N TRP D 498 SHEET 1 J 2 GLN D 462 SER D 463 0 SHEET 2 J 2 THR D 488 LEU D 489 -1 O LEU D 489 N GLN D 462 LINK C GLY A 521 N CSD A 522 1555 1555 1.33 LINK C CSD A 522 N GLY A 523 1555 1555 1.35 LINK C GLY B 521 N CSD B 522 1555 1555 1.34 LINK C CSD B 522 N GLY B 523 1555 1555 1.34 LINK C GLY C 521 N CSD C 522 1555 1555 1.33 LINK C CSD C 522 N GLY C 523 1555 1555 1.33 LINK C GLY D 521 N CSD D 522 1555 1555 1.33 LINK C CSD D 522 N GLY D 523 1555 1555 1.33 CISPEP 1 PRO A 508 PRO A 509 0 0.26 CISPEP 2 PRO B 508 PRO B 509 0 0.26 CISPEP 3 PRO C 508 PRO C 509 0 -0.30 CISPEP 4 PRO D 508 PRO D 509 0 0.83 CRYST1 62.195 84.035 98.750 90.00 90.00 90.00 P 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016078 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011900 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010127 0.00000